These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 29214453)

  • 61. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Central pancreatectomy with external drainage of monolayer pancreaticojejunostomy for prevention of postoperative pancreatic fistula: A retrospective cohort study.
    Yang F; Jin C; Di Y; He H; Hao S; Yao L; Li J; Fu D
    Int J Surg; 2018 Mar; 51():104-108. PubMed ID: 29367037
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical Impact of Neoadjuvant Therapy on Nutritional Status in Pancreatic Cancer.
    Tashiro M; Yamada S; Sonohara F; Takami H; Suenaga M; Hayashi M; Niwa Y; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
    Ann Surg Oncol; 2018 Oct; 25(11):3365-3371. PubMed ID: 30097739
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review.
    Czosnyka NM; Borgert AJ; Smith TJ
    HPB (Oxford); 2017 Oct; 19(10):927-932. PubMed ID: 28747265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pancreatico-jejunostomy decreases post-operative pancreatic fistula incidence and severity after central pancreatectomy.
    Borel F; Ouaissi M; Merdrignac A; Venara A; De Franco V; Sulpice L; Hamy A; Regenet N
    ANZ J Surg; 2018 Jan; 88(1-2):77-81. PubMed ID: 28809096
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neoadjuvant therapy contributes to nodal downstaging of pancreatic cancer.
    Okada K; Uemura K; Kondo N; Sumiyoshi T; Seo S; Otsuka H; Serikawa M; Ishii Y; Tsuboi T; Murakami Y; Takahashi S
    Langenbecks Arch Surg; 2022 Mar; 407(2):623-632. PubMed ID: 34609618
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of preoperative chemotherapy and chemoradiotherapy on pancreatic fistula and other surgical complications after pancreatic resection: a systematic review and meta-analysis of comparative studies.
    van Dongen JC; Wismans LV; Suurmeijer JA; Besselink MG; de Wilde RF; Groot Koerkamp B; van Eijck CHJ
    HPB (Oxford); 2021 Sep; 23(9):1321-1331. PubMed ID: 34099372
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
    Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
    Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Postoperative Outcome of Surgery with Pancreatic Resection for Retroperitoneal Soft Tissue Sarcoma: Results of a Retrospective Bicentric Analysis on 50 Consecutive Patients.
    Flacs M; Faron M; Mir O; Mihoubi F; Sourouille I; Haddag-Miliani L; Dumont S; Terrier P; Levy A; Dousset B; Boudou-Rouquette P; Le Cesne A; Gaujoux S; Honoré C
    J Gastrointest Surg; 2021 Sep; 25(9):2299-2306. PubMed ID: 33236323
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intention to treat outcomes among patients with pancreatic cancer treated using International Study Group on Pancreatic Surgery recommended pathways for resectable and borderline resectable disease.
    Kamarajah SK; Chatzizacharias N; Hodson J; Marcon F; Kalisvaart M; Punia P; Ting Ma Y; Dasari B; Marudanayagam R; Sutcliffe RP; Muiesan P; Mirza DF; Isaac J; Roberts KJ
    ANZ J Surg; 2021 Jul; 91(7-8):1549-1557. PubMed ID: 33576568
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Robotic-Assisted Pancreatic Resections.
    Boggi U; Napoli N; Costa F; Kauffmann EF; Menonna F; Iacopi S; Vistoli F; Amorese G
    World J Surg; 2016 Oct; 40(10):2497-506. PubMed ID: 27206401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer: A Single Institution Experience.
    Rangelova E; Wefer A; Persson S; Valente R; Tanaka K; Orsini N; Segersvärd R; Arnelo U; Del Chiaro M
    Ann Surg; 2021 Mar; 273(3):579-586. PubMed ID: 30946073
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
    J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients.
    Dhayat SA; Tamim ANJ; Jacob M; Ebeling G; Kerschke L; Kabar I; Senninger N
    PLoS One; 2021; 16(6):e0252727. PubMed ID: 34086792
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The falciform/round ligament "flooring," an effective method to reduce life-threatening post-pancreatectomy hemorrhage occurrence.
    Guilbaud T; Faust C; Picaud O; Baumstarck K; Vicenty T; Farvacque G; Vanbrugghe C; Berdah S; Moutardier V; Birnbaum DJ
    Langenbecks Arch Surg; 2023 May; 408(1):192. PubMed ID: 37171647
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Late postpancreatectomy hemorrhage after pancreaticoduodenectomy: is it possible to recognize risk factors?
    Ricci C; Casadei R; Buscemi S; Minni F
    JOP; 2012 Mar; 13(2):193-8. PubMed ID: 22406600
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors.
    Heidsma CM; Tsilimigras DI; van Dieren S; Rocha F; Abbott DE; Fields R; Smith PM; Poultsides GA; Cho C; Dillhoff M; Lopez-Aguiar AG; Kanji Z; Fisher A; Krasnick BA; Idrees K; Makris E; Beems M; van Eijck CHJ; Nieveen van Dijkum EJM; Maithel SK; Pawlik TM
    HPB (Oxford); 2021 Mar; 23(3):413-421. PubMed ID: 32771338
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Propensity Score-Matched Analysis of Robotic vs Open Pancreatoduodenectomy on Incidence of Pancreatic Fistula.
    McMillan MT; Zureikat AH; Hogg ME; Kowalsky SJ; Zeh HJ; Sprys MH; Vollmer CM
    JAMA Surg; 2017 Apr; 152(4):327-335. PubMed ID: 28030724
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pasireotide is not effective in reducing the development of postoperative pancreatic fistula.
    Young S; Sung ML; Lee JA; DiFronzo LA; O'Connor VV
    HPB (Oxford); 2018 Sep; 20(9):834-840. PubMed ID: 30060910
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Perioperative hydrocortisone treatment reduces postoperative pancreatic fistula rate after open distal pancreatectomy. A randomized placebo-controlled trial.
    Antila A; Siiki A; Sand J; Laukkarinen J
    Pancreatology; 2019 Jul; 19(5):786-792. PubMed ID: 31153781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.